WASHINGTON, June 1, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, LLP continues the strategic growth of its Government Law & Policy Practice in the...
In the news release, Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic...
ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that it has received clearance by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to conduct GLORA-4 study (NCT06641414), a global registrational Phase III study of lisaftoclax (APG-2575), a proprietary Bcl-2 inhibitor, in combination with azacitidine (AZA), for the treatment of patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS).
Multicenter Registry Launches to Assess Real-World Outcomes and Clinical Integration of Nonthermal Aliya PEF Ablation
REDWOOD CITY, Calif., Aug. 15, 2025 /PRNewswire/ -- Galvanize Therapeutics...
HOLMDEL, N.J., Aug. 15, 2025 /PRNewswire/ -- The New Jersey Digital Marketing Conference (NJDMC) is back on Thursday, October 23, 2025, bringing together the...
Pan-African People's Studios announces broadcast on ORTM and Africable following the screening
BAMAKO, Mali, Aug. 14, 2025 /PRNewswire/ -- Pan-African People's Studios today announced the premiere...
INCLINE VILLAGE, Nev., Aug. 14, 2025 /PRNewswire/ -- Spacruzzi, the leading manufacturer of luxury hot tub boats, is showcasing its latest innovative design–already making...
Four college students from universities across the country will be awarded scholarships totaling $19,000 for their exceptional essays on topical ethical issues in a...
New initiative combines UNR's renowned ABA curriculum with full tuition sponsorship and Centria's structured practicum program
FARMINGTON HILLS, Mich., Aug. 13, 2025 /PRNewswire/ -- Centria...